AMY SQUEGLIA: Open Payments
NPI 1295897338 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 4 payments from 4 companies in 2025. Trend: 2023 $166 · 2024 $257 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $132 |
| Lilly USA, LLC | 1 | $123 |
| ViiV Healthcare Company | 1 | $122 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $118 |
Products named: ZEPBOUND, APRETUDE, JOURNAVX.
Industry payments across CA — which companies pay providers there.
